Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02230436
Other study ID # PUMCH-GS02
Secondary ID
Status Recruiting
Phase N/A
First received August 16, 2014
Last updated February 20, 2017
Start date July 2014
Est. completion date December 2017

Study information

Verified date August 2016
Source Peking Union Medical College Hospital
Contact Menghua Dai, M.D.
Email daim66@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to demonstrate the hypothesis that early removal of drain can reduce the incidence of intra-abdominal infection and pancreatic fistula after pancreatectomy compared with later removal of drain.


Description:

This study is to analyze the association between the time of removal of drain after pancreatic resection and incidence of intra-abdominal complications, such as intra-abdominal infection and pancreatic leakage. We design a prospective randomized study. Patients with pancreatic and periampullar tumors who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP) are recruited to the study if amylase value in drain(s) is less than 5000 U/L on postoperative day (POD) 1. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 4 or beyond. The primary outcomes are the incidence of intra-abdominal infection and pancreatic fistula; the secondary outcomes include intra-abdominal bleeding, delayed gastric emptying, pulmonary complications, and length of hospital stay.


Recruitment information / eligibility

Status Recruiting
Enrollment 144
Est. completion date December 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Age: >18yr, <75yr

- Patients with pancreatic diseases (including tumor and inflammatory disease) or non-pancreatic tumors (biliary duct cancer or ampullary tumor) who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP)

- The amylase value in drain(s) is less than 5000 U/L on postoperative day 1 and 3.

Exclusion Criteria:

- Reconstruction of the pancreatic remnant by pancreaticogastrostomy

- Intra-abdominal hemorrhage within 72 hours after operation

- Biliary fistula (output of biliary fluid from at least 1 abdominal drain) within 72 hours after operation

- Chylous leakage (milky water) within 72 hours after operation

- The volume of drain effluent (ascites) is greater than 300 ml within 72 hours after operation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Early drain removal
Removing drain(s) on postoperative day 3
Late drain removal
Removing drain(s) on postoperative day 4 or later

Locations

Country Name City State
China Peking Union Medical College Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

References & Publications (3)

Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition.. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. Review. — View Citation

Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007 Nov;142(5):761-8. — View Citation

Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Yeo CJ, Büchler MW. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007 Jul;142(1):20-5. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Intra-abdominal infection Positive cultures of collection of fluid or blood,or persistent fever necessitating treatment with antibiotics and positive detection in image test. Up to postoperative 30 days
Primary Pancreatic fistula The international study group (ISGPF) definition: A drain output of any measurable volume of fluid on or after postoperative day 3 with an amylase content greater than 3 times the serum amylase activity. Three different grades of postoperative fistula (grades A, B, C) are defined according to the clinical impact on the patient's hospital course. Up to postoperative 30 days
Secondary Intra-abdominal bleeding The International Study Group of Pancreatic Surgery (ISGPS) definition: Blood loss through abdominal drains or nasogastric tube;hematemesis or melena; clinical deterioration of the patient; unexplained hypotension or tachycardia; or laboratory findings such as a decreasing hemoglobin concentration. Up to postoperative 30 days
Secondary Delayed gastric emptying The International Study Group of Pancreatic Surgery (ISGPS) definition: Inability to return to a standard diet by the end of the first postoperative week with prolonged nasogastric intubation. Up to postoperative 30 days
Secondary Pulmonary complications Including pulmonary infection and atelectasis. Up to postoperative 30 days
Secondary Length of hospital stay (day) Participants will be followed for the duration of hospital stay, an expected average of 2 weeks. Up to postoperative 2 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06208579 - Feasibility and Effectiveness of Augmented Reality Assistance System for Pancreatic Surgery
Completed NCT00414908 - A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy Phase 3
Completed NCT00559364 - Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Phase 3
Active, not recruiting NCT04431076 - Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Recruiting NCT05297136 - Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy N/A
Not yet recruiting NCT05737875 - Distal Pancreatectomy Pancreatic Fistula Risk Prediction Model Validation Study
Completed NCT03060408 - Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy N/A
Completed NCT02509910 - Implementation of a GDT Algorithm for Major Surgery Patients N/A
Completed NCT01929902 - Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
Terminated NCT02617979 - Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement N/A
Recruiting NCT06126601 - Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Completed NCT02623803 - Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies Phase 4
Terminated NCT02649023 - Deep Venous Thrombosis After Hepatobiliopancreatic Surgery
Completed NCT02814812 - Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery N/A
Active, not recruiting NCT04423731 - Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Recruiting NCT05856474 - Management of Traumatic Pancreas Transection
Not yet recruiting NCT05992857 - Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty N/A
Completed NCT01950845 - Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial N/A
Not yet recruiting NCT04850430 - Gastric Venous Reconstruction After Total Pancreatectomy N/A
Not yet recruiting NCT05722548 - Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis Phase 2